| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $37.00K | $50.00K | $44.00K | $57.00K | $75.00K | $75.00K |
| R&D | – | – | – | – | – | – |
| SG&A | $435.91K | $604.17K | $531.41K | $682.28K | $690.71K | $907.98K |
| Operating Income | -$435.91K | -$604.17K | -$531.41K | -$682.28K | -$690.71K | -$907.98K |
| Interest Expense | – | – | $410.86K | $329.89K | $287.69K | $225.30K |
| Tax Expense | $200.00 | – | – | – | $4.15K | – |
| Net Income | -$1.81M | -$1.60M | -$1.83M | -$2.81M | -$2.77M | -$1.53M |
| EPS (basic) | -0.0400 | -0.0400 | -0.0400 | -0.0700 | -0.0700 | -0.0400 |
| EPS (diluted) | -0.0400 | -0.0400 | -0.0400 | -0.0700 | – | – |
| Shares (diluted) | $42.86M | $42.86M | $41.69M | $41.41M | – | – |